See more : IN8bio, Inc. (INAB) Income Statement Analysis – Financial Results
Complete financial analysis of Cambridge Cognition Holdings Plc (COG.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cambridge Cognition Holdings Plc, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- HLB Co., Ltd. (028300.KQ) Income Statement Analysis – Financial Results
- PACE E-COMMERCE VENTURES LIMIT (PACE.BO) Income Statement Analysis – Financial Results
- Dream Residential Real Estate Investment Trust (DRREF) Income Statement Analysis – Financial Results
- Svenska Cellulosa Aktiebolaget SCA (publ) (SCABY) Income Statement Analysis – Financial Results
- Acrivon Therapeutics, Inc. Common Stock (ACRV) Income Statement Analysis – Financial Results
Cambridge Cognition Holdings Plc (COG.L)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.cambridgecognition.com
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IIV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.52M | 12.61M | 10.09M | 6.74M | 5.04M | 6.13M | 6.73M | 6.88M | 5.04M | 5.80M | 4.15M | 5.68M | 5.58M | 4.83M |
| Cost of Revenue | 2.72M | 3.29M | 2.02M | 1.32M | 1.15M | 900.00K | 622.00K | 986.00K | 590.00K | 866.00K | 490.00K | 1.22M | 919.46K | 805.38K |
| Gross Profit | 10.80M | 9.32M | 8.08M | 5.42M | 3.89M | 5.23M | 6.11M | 5.89M | 4.45M | 4.94M | 3.66M | 4.47M | 4.66M | 4.02M |
| Gross Profit Ratio | 79.90% | 73.91% | 80.04% | 80.36% | 77.21% | 85.33% | 90.76% | 85.66% | 88.30% | 85.07% | 88.19% | 78.58% | 83.52% | 83.32% |
| Research & Development | 3.85M | 2.17M | 1.66M | 1.45M | 1.72M | 1.41M | 1.13M | 890.00K | 1.30M | 1.24M | 1.24M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.14M | 10.10M | 7.44M | 6.09M | 7.01M | 6.75M | 6.49M | 5.86M | 5.62M | 5.58M | 6.76M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 2.98M | -2.00M | -1.56M | -1.58M | -1.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.12M | 8.09M | 5.87M | 4.51M | 5.23M | 6.75M | 6.49M | 5.86M | 5.62M | 5.58M | 6.76M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 1.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.92M | 4.64M | 3.10M |
| Operating Expenses | 14.10M | 10.26M | 7.53M | 5.96M | 6.94M | 6.72M | 6.39M | 5.77M | 5.32M | 5.24M | 6.62M | 5.92M | 4.64M | 3.10M |
| Cost & Expenses | 16.82M | 13.55M | 9.55M | 7.29M | 8.09M | 7.62M | 7.01M | 6.76M | 5.91M | 6.11M | 7.11M | 7.14M | 5.56M | 3.91M |
| Interest Income | 16.00K | 9.00K | 0.00 | 4.00K | 5.00K | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 32.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 168.00K | 16.00K | 11.00K | 9.00K | 4.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.00K | 122.19K | 175.96K | 201.80K |
| Depreciation & Amortization | 665.00K | 94.00K | 149.00K | 138.00K | 162.00K | 57.00K | 77.00K | 68.00K | 56.00K | 38.00K | 40.00K | 37.30K | 27.83K | 22.64K |
| EBITDA | -2.62M | -514.00K | 294.00K | -502.00K | -2.95M | -1.43M | -207.00K | 184.00K | -811.00K | -266.00K | -2.92M | -1.42M | 43.06K | 944.05K |
| EBITDA Ratio | -19.42% | -6.68% | 6.90% | -6.05% | -57.24% | -23.36% | -3.08% | 2.68% | -11.96% | -4.58% | -70.35% | -24.92% | 0.77% | 19.55% |
| Operating Income | -3.31M | -936.00K | 547.00K | -546.00K | -3.05M | -1.49M | -284.00K | 116.00K | -659.00K | -304.00K | -2.96M | -1.45M | 15.23K | 921.41K |
| Operating Income Ratio | -24.45% | -7.42% | 5.42% | -8.10% | -60.45% | -24.26% | -4.22% | 1.69% | -13.07% | -5.24% | -71.31% | -25.58% | 0.27% | 19.08% |
| Total Other Income/Expenses | -152.00K | -7.00K | -11.00K | -5.00K | 1.00K | 0.00 | 0.00 | 0.00 | -208.00K | 9.00K | -32.00K | -122.17K | -175.96K | -201.80K |
| Income Before Tax | -3.46M | -624.00K | 253.00K | -649.00K | -3.12M | -1.49M | -284.00K | 116.00K | -867.00K | -295.00K | -2.99M | -1.58M | -160.73K | 719.61K |
| Income Before Tax Ratio | -25.58% | -4.95% | 2.51% | -9.63% | -61.82% | -24.26% | -4.22% | 1.69% | -17.20% | -5.08% | -72.08% | -27.73% | -2.88% | 14.90% |
| Income Tax Expense | 51.00K | -215.00K | -197.00K | -211.00K | -216.00K | 46.00K | 6.00K | 106.00K | 85.00K | 122.00K | 129.00K | 122.19K | 175.96K | 201.80K |
| Net Income | -3.51M | -409.00K | 450.00K | -438.00K | -2.90M | -1.44M | -257.00K | 272.00K | -782.00K | -173.00K | -2.86M | -1.58M | -160.73K | 719.61K |
| Net Income Ratio | -25.96% | -3.24% | 4.46% | -6.50% | -57.54% | -23.51% | -3.82% | 3.96% | -15.51% | -2.98% | -68.97% | -27.73% | -2.88% | 14.90% |
| EPS | -0.10 | -0.01 | 0.01 | -0.01 | -0.12 | -0.07 | -0.01 | 0.01 | -0.05 | -0.01 | -0.21 | -0.09 | -0.01 | 0.04 |
| EPS Diluted | -0.10 | -0.01 | 0.01 | -0.01 | -0.12 | -0.07 | -0.01 | 0.01 | -0.05 | -0.01 | -0.21 | -0.09 | -0.01 | 0.04 |
| Weighted Avg Shares Out | 34.60M | 31.17M | 31.17M | 29.78M | 23.41M | 20.55M | 19.77M | 19.40M | 16.83M | 16.44M | 13.42M | 16.89M | 16.89M | 16.89M |
| Weighted Avg Shares Out (Dil) | 34.60M | 31.17M | 31.52M | 29.78M | 23.41M | 20.55M | 20.40M | 19.47M | 16.83M | 16.44M | 13.42M | 16.89M | 16.89M | 16.89M |
Source: https://incomestatements.info
Category: Stock Reports